These chemical products are for research and development use only. They are not for diagnostic, therapeutic, cosmetic, or human and animal uses. They are not sold to individuals.

Imatinib

Imatinib is used to treat certain types of leukemia (cancer that begins in the white blood cells) and other cancers and disorders of the blood cells. Imatinib is also used to treat certain types of gastrointestinal stromal tumors (GIST; a type of tumor that grows in the walls of the digestive passages and may spread to other parts of the body). Imatinib is also used to treat dermatofibrosarcoma protuberans (a tumor that forms under the top layer of skin) when the tumor cannot be removed surgically, has spread to other parts of the body, or has come back after surgery. Imatinib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps stop the spread of cancer cells.

Imatinib Impurities

Imatinib EP Impurity H
Impurity chemical structure
CAT Number CHR-9122018-4126
CAS Number 350-03-8
Mol.F C7H7NO
Mol.Wt 121.137 g/mol
Inventory status In-Stock
Imatinib Impurity 8
Impurity chemical structure
CAT Number CHR-9122018-3874
CAS Number 99-94-5
Mol.F C8H8O2
Mol.Wt 136.148 g/mol
Inventory status In-Stock
Imatinib Methane sulfonic acid
Impurity chemical structure
CAT Number CHR-9122018-1655
CAS Number 75-75-2
Mol.F CH4O3S
Mol.Wt 96.106 g/mol
Inventory status In-Stock